Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark J. Zweifel is active.

Publication


Featured researches published by Mark J. Zweifel.


Biofutur | 1997

Glycopeptide antibiotic derivatives

Robin D. G. Cooper; Bret E. Huff; Thalia I. Nicas; John Thomas Indianapolis Quatroche; Michael J. Rodriguez; Nancy June Snyder; Michael A. Staszak; Richard Craig Thompson; Stephen Charles Wilkie; Mark J. Zweifel

The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity aginst a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.


Bioorganic & Medicinal Chemistry Letters | 2000

Syntheses and antifungal activity of pseudomycin side-chain analogues. Part 1.

James Andrew Jamison; Stuart Levy; Xicheng Sun; Doug Zeckner; William L. Current; Mark J. Zweifel; Michael J. Rodriguez; William Wilson Turner; Shu-Hui Chen

We have described herein the syntheses of three novel series of aromatic ring containing pseudomycin side-chain analogues. Preliminary biological evaluations of these analogues clearly indicate that it is possible to synthesize rigid pseudomycin side-chain analogues without compromising in vitro antifungal activity.


Bioorganic & Medicinal Chemistry Letters | 2000

Syntheses and biological evaluation of novel pseudomycin side-chain analogues. Part 2.

Shu-Hui Chen; Xicheng Sun; Robert Boyer; Jonathan W. Paschal; Doug Zeckner; William L. Current; Mark J. Zweifel; Michael J. Rodriguez

A series of aliphatic side-chain analogues of pseudomycin was synthesized and evaluated during the course of our side-chain SAR effort. We found that several of the pseudomycin side-chain analogues (e.g., 10) exhibited good in vitro activity against all three major fungi responsible for systemic fungal infections.


Tetrahedron Letters | 1996

Trimethylamine N-oxide: A novel reagent for the promotion of the retro-aldol reaction of R106-1 (LY295337)

Michael J. Rodriguez; Mark J. Zweifel

Abstract The retro-aldol reaction of R106-1 (LY295337), 1 using trimethylamine N-oxide (TNO) facilitates the removal of the tertiary hydroxy group generating R106-sarcosine, 2 a key synthetic intermediate. The reagent is highly reproducible and provides high yields with no major side products. A side by side comparison of TNO vs. traditional bases is described.


Journal of Labelled Compounds and Radiopharmaceuticals | 1996

Studies towards the synthesis of radiolabeled R106-1(LY295337)

Michael J. Rodriguez; Mark J. Zweifel

A unique semisynthetic pathway has been used as a route to acquire radiolabeled material of a complex natural product, R106. The retro-aldol reaction of R106-1 gave a key intermediate R106-sarcosine that was used in a subsequent aldol reaction to incorporate acetone-[2- 14 C].


The Journal of Antibiotics | 1996

Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity

Robin D. G. Cooper; Nancy June Snyder; Mark J. Zweifel; Michael A. Staszak; Stephen Charles Wilkie; Thalia I. Nicas; Deborah L. Mullen; Thomas F. Butler; Michael J. Rodriguez; Bret E. Huff; Richard Craig Thompson


Antimicrobial Agents and Chemotherapy | 1996

Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.

Thalia I. Nicas; Deborah L. Mullen; Jane E. Flokowitsch; David A. Preston; Nancy June Snyder; Mark J. Zweifel; Stephen Charles Wilkie; Michael J. Rodriguez; Richard Craig Thompson; Robin D. G. Cooper


The Journal of Antibiotics | 1998

Novel Glycopeptide Antibiotics: N-Alkylated Derivatives Active Against Vancomycin-Resistant Enterococci

Michael J. Rodriguez; Nancy June Snyder; Mark J. Zweifel; Stephen Charles Wilkie; Douglas Richard Stack; Robin D. G. Cooper; Thalia I. Nicas; Deborah L. Mullen; Thomas F. Butler; Richard Craig Thompson


Archive | 1997

Glycopeptide antibiotic amide derivatives

Robin D. G. Cooper; Michael J. Rodriguez; Nancy June Snyder; Mark J. Zweifel


The Journal of Antibiotics | 1996

Relationship between Structure and Biological Activity of Novel R106 Analogs

Michael J. Rodriguez; Mark J. Zweifel; James D. Farmer; Robert S. Gordee; Richard J. Loncharich

Collaboration


Dive into the Mark J. Zweifel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge